MAM
ABBV icon

MMA Asset Management’s AbbVie ABBV Stock Holding History

MMA Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Sell
944
-42
-4% -$9.04K 0.08% 169
2026
Q1 		$214K Sell
986
-83
-8% -$18.4K 0.08% 173
2025
Q4 		$244K Sell
1,069
-192
-15% -$43.7K 0.09% 169
2025
Q3 		$292K Buy
+1,261
New +$257K 0.1% 164
2024
Q2 		– Sell
-164
Closed -$29.9K – 121
2024
Q1 		$29.9K Buy
+164
New +$28.3K 0.01% 162

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MMA Asset Management's ABBV Position: Q2 2026 in Review

MMA Asset Management reduced its AbbVie (ABBV) stake by 4.3% in Q2 2026, selling an estimated $9.04K and leaving 944 shares worth $238K. The position accounts for 0.08% of the portfolio, ranked #169.

MMA Asset Management first reported a position in ABBV in Q1 2024 and has held it in 5 quarters since. The position peaked at $292K in Q3 2025. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MMA Asset Management held 944 shares of AbbVie worth $238K as of Q2 2026.
  • MMA Asset Management sold 42 AbbVie shares in Q2 2026, an estimated $9.04K.
  • AbbVie made up 0.08% of MMA Asset Management's portfolio in Q2 2026, its #169 holding.
  • MMA Asset Management first reported a position in AbbVie in Q1 2024 and has held it in 5 quarters since.
  • MMA Asset Management's AbbVie position peaked at $292K in Q3 2025.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MMA Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.